Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells
In chondrogenesis, members of the transforming growth factor-beta (TGF-beta) superfamily play critical roles by inducing gene expression of cartilage-specific molecules. By using a chondrogenic cell line, ATDC5, we investigated the TGF-beta-mediated signaling pathways involved in expression of the a...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2001-04, Vol.276 (17), p.14466-14473 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 14473 |
---|---|
container_issue | 17 |
container_start_page | 14466 |
container_title | The Journal of biological chemistry |
container_volume | 276 |
creator | Watanabe, H de Caestecker, M P Yamada, Y |
description | In chondrogenesis, members of the transforming growth factor-beta (TGF-beta) superfamily play critical roles by inducing gene expression of cartilage-specific molecules. By using a chondrogenic cell line, ATDC5, we investigated the TGF-beta-mediated signaling pathways involved in expression of the aggrecan gene (Agc). At confluency, TGF-beta induced Agc expression within 3 h, and cycloheximide blocked this induction, indicating that de novo protein synthesis is essential for this response. At this stage, TGF-beta induced rapid, transient phosphorylation of Smad2, extracellular signal-activated kinase 1/2 (ERK1/2), and p38 mitogen-activated protein kinase (MAPK). Inhibition of the Smad pathways by transfection with a dominant negative Smad4 construct significantly reduced TGF-beta-induced Agc expression, indicating that Smad signaling is essential for this response. Furthermore, an inhibitor of the ERK1/2 pathway, U0126, or inhibitors of the p38 MAPK pathway, SB203580 and SKF86002, repressed TGF-beta-induced Agc expression in a dose-dependent manner, indicating that ERK1/2 or p38 MAPK activation is also required for TGF-beta-induced Agc expression in confluent ATDC5 cells. In differentiated ATDC5 cells, persistently high basal levels of ERK1/2 and p38 MAPK phosphorylation correlated with elevated basal Agc expression, which was inhibited by incubation with inhibitors of these pathways. Whereas Smad2 was rapidly phosphorylated by TGF-beta and involved in the initial activation of Agc expression in confluent cells, Smad2 activation was not required for maintaining the high level of Agc expression. Taken together, these results suggest an important role for transcriptional cross-talk between Smad and MAPK pathways in expression of early chondrocytic phenotypes and identify important changes in the regulation of Agc expression following chondrocyte differentiation. |
doi_str_mv | 10.1074/jbc.M005724200 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17848265</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17848265</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2770-17ee57a2bab1445df39622654895cc138acccf93db5f3d75cd4903bd9f7cd6033</originalsourceid><addsrcrecordid>eNpFkc1u1DAUhbMAtaVlyxJ5xaqZ-iceJ8tqKAVRhATDOrqxbzJuEzvYDtM-Im-Fh45UbyxZx985956ieMfoilFVXd13evWNUql4xSl9VZxRylnZcFmfFm9ivKf5VA07KU4Z46rmDT0r_m4DuKiDnZP1Dkaig4-xTDA-kA7THtGRnxOYS3Lz4yu74pcEnCGzqMlkkx_QlaCT_QMJ82vwCa0jD9ZBRDJD2u3hKZKAwzJmRSTpYNb7MFk3kCH4fdqRPgN8KLMZlNaZRWcSDENADY5kAyT4OAeMMecjma533plwsLaaXG8_biTROI7xonjdwxjx7fE-L359utluPpd332-_bK7vSs2VoiVTiFIB76BjVSVNL5o152tZ1Y3UmokatNZ9I0wne2GU1KZqqOhM0ytt1lSI8-LDMzeP-3vBmNrJxkMCcOiX2DJVV3UGZuHqWfh_pQH7dg52gvDUMtoeCmtzYe1LYfnD-yN56SY0L_JjW-If85OX7Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17848265</pqid></control><display><type>article</type><title>Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Watanabe, H ; de Caestecker, M P ; Yamada, Y</creator><creatorcontrib>Watanabe, H ; de Caestecker, M P ; Yamada, Y</creatorcontrib><description>In chondrogenesis, members of the transforming growth factor-beta (TGF-beta) superfamily play critical roles by inducing gene expression of cartilage-specific molecules. By using a chondrogenic cell line, ATDC5, we investigated the TGF-beta-mediated signaling pathways involved in expression of the aggrecan gene (Agc). At confluency, TGF-beta induced Agc expression within 3 h, and cycloheximide blocked this induction, indicating that de novo protein synthesis is essential for this response. At this stage, TGF-beta induced rapid, transient phosphorylation of Smad2, extracellular signal-activated kinase 1/2 (ERK1/2), and p38 mitogen-activated protein kinase (MAPK). Inhibition of the Smad pathways by transfection with a dominant negative Smad4 construct significantly reduced TGF-beta-induced Agc expression, indicating that Smad signaling is essential for this response. Furthermore, an inhibitor of the ERK1/2 pathway, U0126, or inhibitors of the p38 MAPK pathway, SB203580 and SKF86002, repressed TGF-beta-induced Agc expression in a dose-dependent manner, indicating that ERK1/2 or p38 MAPK activation is also required for TGF-beta-induced Agc expression in confluent ATDC5 cells. In differentiated ATDC5 cells, persistently high basal levels of ERK1/2 and p38 MAPK phosphorylation correlated with elevated basal Agc expression, which was inhibited by incubation with inhibitors of these pathways. Whereas Smad2 was rapidly phosphorylated by TGF-beta and involved in the initial activation of Agc expression in confluent cells, Smad2 activation was not required for maintaining the high level of Agc expression. Taken together, these results suggest an important role for transcriptional cross-talk between Smad and MAPK pathways in expression of early chondrocytic phenotypes and identify important changes in the regulation of Agc expression following chondrocyte differentiation.</description><identifier>ISSN: 0021-9258</identifier><identifier>DOI: 10.1074/jbc.M005724200</identifier><identifier>PMID: 11278290</identifier><language>eng</language><publisher>United States</publisher><subject>Agc gene ; aggrecan ; Aggrecans ; Animals ; Butadienes - pharmacology ; Cell Differentiation ; Cell Line ; Cell Nucleus - metabolism ; Chondrocytes - cytology ; Cycloheximide - pharmacology ; DNA-Binding Proteins - metabolism ; Dose-Response Relationship, Drug ; Enzyme Activation ; ERK1 protein ; ERK2 protein ; Extracellular Matrix Proteins ; extracellular signal-regulated kinase ; Gene Expression Regulation, Enzymologic ; Genes, Dominant ; Imidazoles - pharmacology ; Immunoblotting ; Lectins, C-Type ; Luciferases - metabolism ; Mice ; Mitogen-Activated Protein Kinase 1 - metabolism ; Mitogen-Activated Protein Kinase 3 ; Mitogen-Activated Protein Kinases - metabolism ; Nitriles - pharmacology ; p38 Mitogen-Activated Protein Kinases ; Phosphorylation ; Protein Synthesis Inhibitors - pharmacology ; Proteoglycans - biosynthesis ; Pyridines - pharmacology ; Reverse Transcriptase Polymerase Chain Reaction ; Signal Transduction ; Smad Proteins ; Smad2 protein ; Thiazoles - pharmacology ; Time Factors ; Trans-Activators - metabolism ; Transcription, Genetic ; Transfection ; Transforming Growth Factor beta - metabolism</subject><ispartof>The Journal of biological chemistry, 2001-04, Vol.276 (17), p.14466-14473</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2770-17ee57a2bab1445df39622654895cc138acccf93db5f3d75cd4903bd9f7cd6033</citedby><cites>FETCH-LOGICAL-c2770-17ee57a2bab1445df39622654895cc138acccf93db5f3d75cd4903bd9f7cd6033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11278290$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Watanabe, H</creatorcontrib><creatorcontrib>de Caestecker, M P</creatorcontrib><creatorcontrib>Yamada, Y</creatorcontrib><title>Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>In chondrogenesis, members of the transforming growth factor-beta (TGF-beta) superfamily play critical roles by inducing gene expression of cartilage-specific molecules. By using a chondrogenic cell line, ATDC5, we investigated the TGF-beta-mediated signaling pathways involved in expression of the aggrecan gene (Agc). At confluency, TGF-beta induced Agc expression within 3 h, and cycloheximide blocked this induction, indicating that de novo protein synthesis is essential for this response. At this stage, TGF-beta induced rapid, transient phosphorylation of Smad2, extracellular signal-activated kinase 1/2 (ERK1/2), and p38 mitogen-activated protein kinase (MAPK). Inhibition of the Smad pathways by transfection with a dominant negative Smad4 construct significantly reduced TGF-beta-induced Agc expression, indicating that Smad signaling is essential for this response. Furthermore, an inhibitor of the ERK1/2 pathway, U0126, or inhibitors of the p38 MAPK pathway, SB203580 and SKF86002, repressed TGF-beta-induced Agc expression in a dose-dependent manner, indicating that ERK1/2 or p38 MAPK activation is also required for TGF-beta-induced Agc expression in confluent ATDC5 cells. In differentiated ATDC5 cells, persistently high basal levels of ERK1/2 and p38 MAPK phosphorylation correlated with elevated basal Agc expression, which was inhibited by incubation with inhibitors of these pathways. Whereas Smad2 was rapidly phosphorylated by TGF-beta and involved in the initial activation of Agc expression in confluent cells, Smad2 activation was not required for maintaining the high level of Agc expression. Taken together, these results suggest an important role for transcriptional cross-talk between Smad and MAPK pathways in expression of early chondrocytic phenotypes and identify important changes in the regulation of Agc expression following chondrocyte differentiation.</description><subject>Agc gene</subject><subject>aggrecan</subject><subject>Aggrecans</subject><subject>Animals</subject><subject>Butadienes - pharmacology</subject><subject>Cell Differentiation</subject><subject>Cell Line</subject><subject>Cell Nucleus - metabolism</subject><subject>Chondrocytes - cytology</subject><subject>Cycloheximide - pharmacology</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme Activation</subject><subject>ERK1 protein</subject><subject>ERK2 protein</subject><subject>Extracellular Matrix Proteins</subject><subject>extracellular signal-regulated kinase</subject><subject>Gene Expression Regulation, Enzymologic</subject><subject>Genes, Dominant</subject><subject>Imidazoles - pharmacology</subject><subject>Immunoblotting</subject><subject>Lectins, C-Type</subject><subject>Luciferases - metabolism</subject><subject>Mice</subject><subject>Mitogen-Activated Protein Kinase 1 - metabolism</subject><subject>Mitogen-Activated Protein Kinase 3</subject><subject>Mitogen-Activated Protein Kinases - metabolism</subject><subject>Nitriles - pharmacology</subject><subject>p38 Mitogen-Activated Protein Kinases</subject><subject>Phosphorylation</subject><subject>Protein Synthesis Inhibitors - pharmacology</subject><subject>Proteoglycans - biosynthesis</subject><subject>Pyridines - pharmacology</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Signal Transduction</subject><subject>Smad Proteins</subject><subject>Smad2 protein</subject><subject>Thiazoles - pharmacology</subject><subject>Time Factors</subject><subject>Trans-Activators - metabolism</subject><subject>Transcription, Genetic</subject><subject>Transfection</subject><subject>Transforming Growth Factor beta - metabolism</subject><issn>0021-9258</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkc1u1DAUhbMAtaVlyxJ5xaqZ-iceJ8tqKAVRhATDOrqxbzJuEzvYDtM-Im-Fh45UbyxZx985956ieMfoilFVXd13evWNUql4xSl9VZxRylnZcFmfFm9ivKf5VA07KU4Z46rmDT0r_m4DuKiDnZP1Dkaig4-xTDA-kA7THtGRnxOYS3Lz4yu74pcEnCGzqMlkkx_QlaCT_QMJ82vwCa0jD9ZBRDJD2u3hKZKAwzJmRSTpYNb7MFk3kCH4fdqRPgN8KLMZlNaZRWcSDENADY5kAyT4OAeMMecjma533plwsLaaXG8_biTROI7xonjdwxjx7fE-L359utluPpd332-_bK7vSs2VoiVTiFIB76BjVSVNL5o152tZ1Y3UmokatNZ9I0wne2GU1KZqqOhM0ytt1lSI8-LDMzeP-3vBmNrJxkMCcOiX2DJVV3UGZuHqWfh_pQH7dg52gvDUMtoeCmtzYe1LYfnD-yN56SY0L_JjW-If85OX7Q</recordid><startdate>20010427</startdate><enddate>20010427</enddate><creator>Watanabe, H</creator><creator>de Caestecker, M P</creator><creator>Yamada, Y</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TM</scope></search><sort><creationdate>20010427</creationdate><title>Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells</title><author>Watanabe, H ; de Caestecker, M P ; Yamada, Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2770-17ee57a2bab1445df39622654895cc138acccf93db5f3d75cd4903bd9f7cd6033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Agc gene</topic><topic>aggrecan</topic><topic>Aggrecans</topic><topic>Animals</topic><topic>Butadienes - pharmacology</topic><topic>Cell Differentiation</topic><topic>Cell Line</topic><topic>Cell Nucleus - metabolism</topic><topic>Chondrocytes - cytology</topic><topic>Cycloheximide - pharmacology</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme Activation</topic><topic>ERK1 protein</topic><topic>ERK2 protein</topic><topic>Extracellular Matrix Proteins</topic><topic>extracellular signal-regulated kinase</topic><topic>Gene Expression Regulation, Enzymologic</topic><topic>Genes, Dominant</topic><topic>Imidazoles - pharmacology</topic><topic>Immunoblotting</topic><topic>Lectins, C-Type</topic><topic>Luciferases - metabolism</topic><topic>Mice</topic><topic>Mitogen-Activated Protein Kinase 1 - metabolism</topic><topic>Mitogen-Activated Protein Kinase 3</topic><topic>Mitogen-Activated Protein Kinases - metabolism</topic><topic>Nitriles - pharmacology</topic><topic>p38 Mitogen-Activated Protein Kinases</topic><topic>Phosphorylation</topic><topic>Protein Synthesis Inhibitors - pharmacology</topic><topic>Proteoglycans - biosynthesis</topic><topic>Pyridines - pharmacology</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Signal Transduction</topic><topic>Smad Proteins</topic><topic>Smad2 protein</topic><topic>Thiazoles - pharmacology</topic><topic>Time Factors</topic><topic>Trans-Activators - metabolism</topic><topic>Transcription, Genetic</topic><topic>Transfection</topic><topic>Transforming Growth Factor beta - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Watanabe, H</creatorcontrib><creatorcontrib>de Caestecker, M P</creatorcontrib><creatorcontrib>Yamada, Y</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nucleic Acids Abstracts</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Watanabe, H</au><au>de Caestecker, M P</au><au>Yamada, Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2001-04-27</date><risdate>2001</risdate><volume>276</volume><issue>17</issue><spage>14466</spage><epage>14473</epage><pages>14466-14473</pages><issn>0021-9258</issn><abstract>In chondrogenesis, members of the transforming growth factor-beta (TGF-beta) superfamily play critical roles by inducing gene expression of cartilage-specific molecules. By using a chondrogenic cell line, ATDC5, we investigated the TGF-beta-mediated signaling pathways involved in expression of the aggrecan gene (Agc). At confluency, TGF-beta induced Agc expression within 3 h, and cycloheximide blocked this induction, indicating that de novo protein synthesis is essential for this response. At this stage, TGF-beta induced rapid, transient phosphorylation of Smad2, extracellular signal-activated kinase 1/2 (ERK1/2), and p38 mitogen-activated protein kinase (MAPK). Inhibition of the Smad pathways by transfection with a dominant negative Smad4 construct significantly reduced TGF-beta-induced Agc expression, indicating that Smad signaling is essential for this response. Furthermore, an inhibitor of the ERK1/2 pathway, U0126, or inhibitors of the p38 MAPK pathway, SB203580 and SKF86002, repressed TGF-beta-induced Agc expression in a dose-dependent manner, indicating that ERK1/2 or p38 MAPK activation is also required for TGF-beta-induced Agc expression in confluent ATDC5 cells. In differentiated ATDC5 cells, persistently high basal levels of ERK1/2 and p38 MAPK phosphorylation correlated with elevated basal Agc expression, which was inhibited by incubation with inhibitors of these pathways. Whereas Smad2 was rapidly phosphorylated by TGF-beta and involved in the initial activation of Agc expression in confluent cells, Smad2 activation was not required for maintaining the high level of Agc expression. Taken together, these results suggest an important role for transcriptional cross-talk between Smad and MAPK pathways in expression of early chondrocytic phenotypes and identify important changes in the regulation of Agc expression following chondrocyte differentiation.</abstract><cop>United States</cop><pmid>11278290</pmid><doi>10.1074/jbc.M005724200</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9258 |
ispartof | The Journal of biological chemistry, 2001-04, Vol.276 (17), p.14466-14473 |
issn | 0021-9258 |
language | eng |
recordid | cdi_proquest_miscellaneous_17848265 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Agc gene aggrecan Aggrecans Animals Butadienes - pharmacology Cell Differentiation Cell Line Cell Nucleus - metabolism Chondrocytes - cytology Cycloheximide - pharmacology DNA-Binding Proteins - metabolism Dose-Response Relationship, Drug Enzyme Activation ERK1 protein ERK2 protein Extracellular Matrix Proteins extracellular signal-regulated kinase Gene Expression Regulation, Enzymologic Genes, Dominant Imidazoles - pharmacology Immunoblotting Lectins, C-Type Luciferases - metabolism Mice Mitogen-Activated Protein Kinase 1 - metabolism Mitogen-Activated Protein Kinase 3 Mitogen-Activated Protein Kinases - metabolism Nitriles - pharmacology p38 Mitogen-Activated Protein Kinases Phosphorylation Protein Synthesis Inhibitors - pharmacology Proteoglycans - biosynthesis Pyridines - pharmacology Reverse Transcriptase Polymerase Chain Reaction Signal Transduction Smad Proteins Smad2 protein Thiazoles - pharmacology Time Factors Trans-Activators - metabolism Transcription, Genetic Transfection Transforming Growth Factor beta - metabolism |
title | Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T02%3A19%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transcriptional%20cross-talk%20between%20Smad,%20ERK1/2,%20and%20p38%20mitogen-activated%20protein%20kinase%20pathways%20regulates%20transforming%20growth%20factor-beta-induced%20aggrecan%20gene%20expression%20in%20chondrogenic%20ATDC5%20cells&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Watanabe,%20H&rft.date=2001-04-27&rft.volume=276&rft.issue=17&rft.spage=14466&rft.epage=14473&rft.pages=14466-14473&rft.issn=0021-9258&rft_id=info:doi/10.1074/jbc.M005724200&rft_dat=%3Cproquest_cross%3E17848265%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17848265&rft_id=info:pmid/11278290&rfr_iscdi=true |